Astera Labs (NASDAQ:ALAB) Stock Price Down 6.7% Following Analyst Downgrade

Key Points

• Shares of Astera Labs fell 6.7% mid-day after Wall Street Zen downgraded the stock from buy to hold; the shares traded as low as $153.95 and last at $156.35 on significantly lighter volume (~2.02M shares, down 61% vs. average).
• Despite the downgrade, Astera Labs beat Q3 expectations with $0.49 EPS vs. $0.39 consensus and $230.6M revenue (+103.9% YoY) and issued Q4 EPS guidance of $0.50–$0.51; analysts' consensus is a "Moderate Buy" with a $181.59 price target.
• Insiders sold 434,480 shares worth about $77.9M in the last 90 days (insiders own 12.5%), while institutional investors hold 60.47% of the company’s stock.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) dropped 6.7% during mid-day trading on Wednesday after Wall Street Zen downgraded the stock from a buy rating to a hold rating. The company traded as low as $153.95 and last traded at $156.3520. Approximately 2,018,595 shares traded hands during trading, a decline of 61% from the average daily volume of 5,238,438 shares. The stock had previously closed at $167.55.

Several other equities analysts have also weighed in on the stock. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They issued a "neutral" rating and a $230.00 price objective on the stock. Evercore ISI lifted their price target on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. TD Cowen dropped their target price on Astera Labs from $225.00 to $170.00 and set a "hold" rating for the company in a report on Wednesday, November 5th. Barclays restated an "equal weight" rating and issued a $155.00 price target on shares of Astera Labs in a research note on Monday, October 20th. Finally, Stifel Nicolaus lifted their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the stock a "buy" rating in a research note on Wednesday, November 5th. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $181.59.

Insider Activity at Astera Labs

In related news, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the sale, the director owned 97,351 shares in the company, valued at approximately $17,369,365.42. This trade represents a 18.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the transaction, the general counsel owned 151,573 shares of the company's stock, valued at approximately $29,126,267.68. This represents a 6.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 434,480 shares of company stock worth $77,881,380 in the last 90 days. Corporate insiders own 12.50% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Alliancebernstein L.P. lifted its stake in shares of Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after acquiring an additional 4,478,741 shares during the last quarter. Atreides Management LP lifted its stake in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the period. Vanguard Group Inc. boosted its stake in shares of Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company's stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. FengHe Fund Management Pte. Ltd. bought a new stake in shares of Astera Labs during the 2nd quarter valued at about $106,772,000. Finally, Bank of Nova Scotia grew its position in shares of Astera Labs by 3,742.2% during the 1st quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock worth $57,546,000 after buying an additional 939,300 shares during the period. Institutional investors own 60.47% of the company's stock.

Astera Labs Stock Performance

The company has a market cap of $26.29 billion, a P/E ratio of 139.81, a price-to-earnings-growth ratio of 3.24 and a beta of 1.38. The firm's 50 day moving average price is $195.68 and its two-hundred day moving average price is $142.59.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same period in the prior year, the business earned $0.23 EPS. The firm's revenue for the quarter was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.